At Griffith University in Australia, researchers have uncovered a circular-economy solution hiding in plain sight: human urine, analyzed across 35 global studies, could recover up to 80% of the nitrogen and 50% of the phosphorus currently lost to wastewater. The finding arrives at a moment when global fertilizer supply chains are strained and synthetic fertilizer production demands enormous energy. Urine recycling could reshape agriculture in water-scarce regions, off-grid communities, and even private gardens—but first, a set of real health risks must be understood and managed.
The promise is genuine. Human urine is remarkably nutrient-rich, and storage itself can act as a natural treatment: a process called urea hydrolysis breaks down urine and produces ammonia, which kills many pathogens. Switzerland has already approved a urine-derived fertilizer called Aurin, developed through the VUNA (Valorization of Urine Nutrients in Africa) project. Germany, New Zealand, and Australia have all piloted similar systems. The circular logic is compelling—nutrient recovery from waste streams could reduce reliance on energy-intensive synthetic fertilizers and help address global resource shortages.
Yet the Griffith team, led by doctoral researcher Johanna Engels and co-authors including Professor Cara Beal and Associate Professor Md Sayed Iftekhar, discovered that the biggest risk is not urine itself, but cross-contamination. When fecal matter mixes in during collection and storage, harmful pathogens capable of causing gastrointestinal illness can proliferate. Engels emphasized the core challenge: "Urine has enormous potential as a renewable fertilizer, but our review shows we don't yet fully understand the health risks."
The picture grows more complex when examined closely. While storage can reduce bacteria through the natural ammonia process, effectiveness varies widely depending on temperature, pH, and dilution with water—conditions difficult to control outside a laboratory. Even more concerning, viruses (which are rarely studied in existing research) may persist far longer than bacteria, potentially making current safety assessments incomplete. Professor Beal flagged another emerging risk: residual pharmaceuticals in urine, including antibiotics and antimicrobial compounds, are not consistently removed during treatment. These could contribute to the spread of antibiotic-resistant bacteria, and while uptake in crops appears minimal, these substances may still migrate through soil into water systems.
The VUNA project itself illustrates both the potential and the obstacles. Its fertilizer product gained official approval in Switzerland—a genuine milestone—yet scaling proved difficult due to collection logistics, cost, community awareness, and social acceptance. These are not mere technical problems; they reveal how transforming waste into resource requires not just innovation but cultural shift.
Despite the challenges, the research team sees a genuine path forward. Associate Professor Iftekhar described urine-derived fertilizers as having "strong potential to support circular economy goals." But realizing that potential requires further research into pathogen levels, improved treatment methods, and standardized safety guidelines. The authors emphasized that "addressing these uncertainties is critical to building public confidence and enabling safe, large-scale use."
The science is neither rejection nor unbridled enthusiasm—it is clarity. Human urine represents a real solution to real resource pressures, but only if treated with rigor. As fertilizer supplies tighten and agricultural demand grows, the question is not whether to pursue this path, but how to do it safely and at scale.